Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells

Overview

Journal Front Pharmacol

Date 2021 Nov 5

PMID 34737698

Citations 14

Authors

Yu-Zhu Zhang

Jia-Yao Yang

Rui-Xian Wu

Chen Fang

Hai Lu

Hua-Chao Li

Dong-Mei Li

Hua-Li Zuo

Li-Ping Ren

Xiao-Yuan Liu

Rui Xu

Jia-Huai Wen

Hsien-Da Huang

Ri Hong

Qian-Jun Chen

Affiliations

Soon will be listed here.

Abstract

Xihuang pill, an approved Chinese medicine formula (state medical permit number. Z11020073), is a commonly used adjuvant drug for cancer patients in China. Xihuang pill has a satisfactory effect in treating breast cancer in clinics, especially triple-negative breast cancer (TNBC), which is the most aggressive type of breast cancer, and finite effective therapies. However, the mechanism of Xihuang pill in treating TNBC remains unclear. The present study aims to explore the pharmacological mechanism of Xihuang pill in treating advanced TNBC. We identified the main chemical components of Xihuang pill by using HPLC-Q-TOF-MS/MS. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis shows that serum containing Xihuang pill (XS) had no obvious killing effect on any subtype of breast cancer cells, but it inhibited mammosphere colony formation of two TNBC cell lines (4T1 and HCC1806 cells) and could enhance the inhibitory effect of paclitaxel (PTX) on the proliferation of 4T1 and HCC1806 cells when combined with PTX. Seventy-six active compounds in Xihuang pill, their 300 protein targets, and 16667 TNBC stem cell-related genes were identified. The drug-herb-active compound-target gene-disease network and enrichment analyses were constructed with 190 overlapping candidate targets. Through text mining and molecular docking, the target gene NR3C2 and its active compound naringenin were selected for further validation. According to the TCGA database, we observed that a high expression of NR3C2 promoted a higher survival probability regarding overall survival (OS). experiments indicated that naringenin presented an identical effect to XS, possibly by regulating the NR3C2 expression. Overall, this study explored the effect of Xihuang pill in treating advanced TNBC cells and showed that naringenin, which is the key active compound of Xihuang pill, could lessen the stemness of TNBC cells to produce a synergistic effect on PTX by regulating the NR3C2 gene.

Citing Articles

Evaluation of Xihuang Pill in inducing pyroptosis in glioma cells through modulation of miR-21-5p.

Tang N, Geng N, Zhu X 3 Biotech. 2024; 14(12):295.

PMID: 39529806 PMC: 11550298. DOI: 10.1007/s13205-024-04148-7.

Integrating machine learning and multi-omics analysis to develop an asparagine metabolism immunity index for improving clinical outcome and drug sensitivity in lung adenocarcinoma.

Li C, Mao Y, Hu J, Su C, Li M, Tan H Immunol Res. 2024; 72(6):1447-1469.

PMID: 39320693 DOI: 10.1007/s12026-024-09544-y.

Uncovering the anti-breast cancer activity potential of east Kalimantan propolis by In vitro and bioinformatics analysis.

Kustiawan P, Siregar K, Syaifie P, Zein Muttaqin F, Ibadillah D, Jauhar M Heliyon. 2024; 10(13):e33636.

PMID: 39071605 PMC: 11283153. DOI: 10.1016/j.heliyon.2024.e33636.

Revealing Molecular Mechanisms of the Bioactive Saponins from Edible Root of in Combating Obesity.

Han B, Luo J, Xu B Plants (Basel). 2024; 13(8).

PMID: 38674532 PMC: 11053671. DOI: 10.3390/plants13081123.

Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal Cancer and Radiation Enteritis.

Lv M, Ding R, Ma P, Feng Y, Zeng S, Zhang Y Curr Pharm Des. 2024; 30(9):683-701.

PMID: 38415445 DOI: 10.2174/0113816128287232240213105913.

References

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

De Giorgi U, Rosti G, Frassineti L, Kopf B, Giovannini N, Zumaglini F . High-dose chemotherapy for triple negative breast cancer. Ann Oncol. 2006; 18(1):202-203. DOI: 10.1093/annonc/mdl306. View

Arriza J, Weinberger C, Cerelli G, Glaser T, Handelin B, Housman D . Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987; 237(4812):268-75. DOI: 10.1126/science.3037703. View

Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao L . miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother. 2017; 96:1341-1348. DOI: 10.1016/j.biopha.2017.11.074. View

Huang C, Chang H, Su S, Chen W, Chang Y, Lee Y . Traditional Chinese medicine is associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment. J Ethnopharmacol. 2018; 229:15-21. DOI: 10.1016/j.jep.2018.09.030. View

Reya T, Morrison S, Clarke M, Weissman I . Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-11. DOI: 10.1038/35102167. View

Horisberger J, Rossier B . Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension. 1992; 19(3):221-7. DOI: 10.1161/01.hyp.19.3.221. View

Ru J, Li P, Wang J, Zhou W, Li B, Huang C . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6:13. PMC: 4001360. DOI: 10.1186/1758-2946-6-13. View

Han K, Chen P, Hong M, Hseu Y, Chen K, Hsu L . Naringenin Attenuated Prostate Cancer Invasion Reversal of Epithelial-to-Mesenchymal Transition and Inhibited uPA Activity. Anticancer Res. 2018; 38(12):6753-6758. DOI: 10.21873/anticanres.13045. View

10.

Zhao Z, Zhang M, Duan X, Deng T, Qiu H, Zeng G . Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma. J Cell Physiol. 2018; 233(10):6825-6838. DOI: 10.1002/jcp.26550. View

11.

Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

12.

Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F . Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell. 2011; 2(6):507-16. PMC: 4875175. DOI: 10.1007/s13238-011-1056-8. View

13.

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S . The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1-1.30.33. DOI: 10.1002/cpbi.5. View

14.

Chen Y, Chang Y, Wang K, Chen P, Hseu Y, Chen K . Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms. Environ Toxicol. 2018; 34(3):233-239. DOI: 10.1002/tox.22677. View

15.

Chen S, Wu S, Li W, Chen X, Dong X, Tan G . Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approaches. Mol Biosyst. 2014; 10(12):3310-21. DOI: 10.1039/c4mb00048j. View

16.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

17.

Park S, Goldstein D, Krishnan A, Lin C, Friedlander M, Cassidy J . Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin. 2014; 63(6):419-37. DOI: 10.3322/caac.21204. View

18.

Seeliger D, de Groot B . Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010; 24(5):417-22. PMC: 2881210. DOI: 10.1007/s10822-010-9352-6. View

19.

Jiang Y, Ma D, Suo C, Shi J, Xue M, Hu X . Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell. 2019; 35(3):428-440.e5. DOI: 10.1016/j.ccell.2019.02.001. View

20.

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View